Glucosamine sulfate · supplement
Evidence tier: weak
A foundational joint cartilage building block, sulfate form has the best clinical evidence.
Glucosamine is an amino sugar and a precursor to the glycosaminoglycans that make up cartilage matrix, so the intuition is that supplying the building block supports cartilage repair. This is the entire theoretical case and it is a substrate availability argument, not a demonstrated mechanism. It has never been shown that oral glucosamine reaches human joint cartilage in a concentration that changes matrix synthesis, and the clinical trials designed to detect the downstream effect of that mechanism, on both pain and joint space narrowing, largely did not find one.
Weak, and unusually so for an ingredient this heavily sold: glucosamine has been tested more rigorously than almost any other supplement on this list, and it largely failed. The decisive trial is GAIT (Clegg, New England Journal of Medicine, 2006, 354(8):795 to 808), an NIH funded, multicentre, double blind study of 1,583 people with painful knee osteoarthritis, with placebo AND an active control (celecoxib). Its primary endpoint was NEGATIVE: glucosamine, chondroitin and the combination showed no significant difference from placebo, while the celecoxib arm did separate from placebo, proving the trial could detect a real analgesic effect and simply did not find one for glucosamine. The independent pooling agrees. Wandel's network meta analysis (BMJ, 2010, 10 trials, 3,803 patients) found the difference from placebo on a 10 cm pain scale was 0.4 cm for glucosamine, and for none of the estimates did the credible interval cross the threshold of a minimal clinically important difference, concluding no clinically relevant effect on either pain or joint space. Funding source is the fault line running through this literature: the positive long term trials were run by the manufacturer, and effects shrink toward nothing when analysis is restricted to large, well designed, independent trials. The guidelines have followed the independent evidence. The 2019 American College of Rheumatology and Arthritis Foundation guideline STRONGLY RECOMMENDS AGAINST glucosamine, on the stated grounds that the best data do not show any important benefits. NCCIH reports that guideline alongside a softer 2021 orthopaedic surgeons guideline that calls the evidence inconsistent, and NCCIH's own summary is that the evidence remains inconsistent and uncertain. On joint structure, NCCIH notes the trials conflict, and the US structural study found no improvement over placebo.
1,500 mg daily, taken as a single dose with food, which is the dose used in essentially every trial including GAIT. The sulfate salt is the form with the positive literature, but that literature is also the industry funded literature, so the form distinction should not be sold as an evidence distinction.
1500 mg daily, ideally as a single dose with food.
Caution with shellfish allergy (most glucosamine is shellfish derived; vegetarian fermented sources available).
Pregnancy: caution
Breastfeeding: caution
Active compounds: glucosamine sulfate
Remedies using Glucosamine Sulfate · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.